Yasunari Kashihara
Director/Board Member at ONCOLYS BIOPHARMA INC.
Net worth: 507 895 $ as of 29/04/2024
Profile
Yasunari Kashihara is currently the Director & Head-Business Development at Oncolys BioPharma, Inc., Director at Unleash Immuno Oncolytics, Inc., Director at Precision Virologics, Inc., Director at Oncolys USA, Inc., and President at Liquid Biotech USA, Inc. He previously held positions as President & Chief Executive Officer at UMN Pharma, Inc., Licensing Manager at Santen Pharmaceutical Co., Ltd., and Pharmacological Researcher at Ciba-Geigy Japan Ltd.
He obtained an MBA from Trinity College Dublin in 2002 and completed undergraduate and graduate studies at Kyoto University.
He also graduated from Kyoto Pharmaceutical University in 1991 and Osaka Prefectural Semboku High School in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ONCOLYS BIOPHARMA, INC.
0.56% | 30/12/2022 | 115,000 ( 0.56% ) | 507 895 $ | 29/04/2024 |
Yasunari Kashihara active positions
| Companies | Position | Start |
|---|---|---|
| ONCOLYS BIOPHARMA INC. | Director/Board Member | 29/02/2008 |
Precision Virologics, Inc.
 Precision Virologics, Inc. BiotechnologyHealth Technology Precision Virologics, Inc. develops biologically targeted vaccines for emerging infectious diseases. The company was founded by David T. Curiel in 2017 and is headquartered in Saint Louis, MO. | Director/Board Member | 31/03/2017 |
Liquid Biotech USA, Inc.
 Liquid Biotech USA, Inc. Medical/Nursing ServicesHealth Services Liquid Biotech USA, Inc. provides cancer diagnosing services. The private company is based in Philadelphia, PA. | President | 31/10/2017 |
Unleash Immuno Oncolytics, Inc.
 Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | Director/Board Member | 31/01/2018 |
| Oncolys USA, Inc. | Director/Board Member | 31/12/2019 |
Former positions of Yasunari Kashihara
| Companies | Position | End |
|---|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| Ciba-Geigy Japan Ltd. | Corporate Officer/Principal | - |
| UMN PHARMA INC. | President | - |
Training of Yasunari Kashihara
| Trinity College Dublin | Masters Business Admin |
| Kyoto University | Graduate Degree |
| Kyoto Pharmaceutical University | Graduate Degree |
| Osaka Prefectural Semboku High School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| ONCOLYS BIOPHARMA INC. | Health Technology |
| Private companies | 6 |
|---|---|
UMN Pharma, Inc.
 UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan. | Health Technology |
| Ciba-Geigy Japan Ltd. | |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | Health Technology |
Precision Virologics, Inc.
Precision Virologics, Inc. BiotechnologyHealth Technology Precision Virologics, Inc. develops biologically targeted vaccines for emerging infectious diseases. The company was founded by David T. Curiel in 2017 and is headquartered in Saint Louis, MO. | Health Technology |
Liquid Biotech USA, Inc.
Liquid Biotech USA, Inc. Medical/Nursing ServicesHealth Services Liquid Biotech USA, Inc. provides cancer diagnosing services. The private company is based in Philadelphia, PA. | Health Services |
| Oncolys USA, Inc. |
- Stock Market
- Insiders
- Yasunari Kashihara
